NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Leuko Labs

Leuko Labs

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://leuko.com/

Last Round

Grant

Jul 23, 2024

Total Funding Raised

$12.4M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Leuko Labs is a medical device company developing PointCheck, a non-invasive device that monitors white blood cell levels for cancer patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

remote patient monitoringRPMnon-invasive monitoringwhite blood cell monitoringdigital healthmedical deviceoncology careneutropenia managementhealth IoTpoint of carePOCvirtual careconnected healthdiagnostic serviceshospital at home

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Leuko Labs Comparables

Compare Leuko Labs with similar companies based on industry and business-model similarity.

Leuko Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RizLab Health
81%
Alacrity Care
78%
Entia
77%

Leuko Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 23, 2024
Series ASep 23, 2022
SeedJul 17, 2019
GrantJun 5, 2018
AcceleratorMay 11, 2018

Key People

Founding team and executive leadership

Alvaro Sanchez-Ferro

Cofounder Chief Medical Officer

Founding Team

Ian Butterworth

Cofounder CTO

Founding Team

Carlos Castro Gonzalez

Co-Founder And CEO

Founding Team

Leuko Labs Investors

Notable investors and investment history

Leuko Labs investors
InvestorRounds
National Cancer InstituteGrant
Good Growth CapitalSeries A, Seed
Nina CapitalSeed, Series A
IAG Capital PartnersSeries A
NIH RADxGrant
MassChallenge IsraelGrant
MIT Alumni Angels of BostonSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 15, 2026

    Grew 27% QoQ, from 15 to 19 employees.

  • Sep 23, 2022

    $5M round led by Health Technology Holding.

Leuko Labs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Leuko Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Leuko Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range19
Year Founded2019
Last FundingJul 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.